MiR-205 also exerts inhibitory effects on cellular invasiveness and migration in prostate cancer and glioblastoma cells, through down-regulation of the protein kinase Cε and low-density lipoprotein receptor-related protein 1, respectively [36,37]. Here, LRP1 is linked to prostate cancer.